In summary, despite the limitations, this meta-analysis suggests that donors or recipients with TGF-β1 rs1800469 polymorphism and donors with TGF-β1 rs1800470 polymorphism might be associated with reduced GVHD risk. Here, TGFB1 is linked to graft versus host disease.